EGF domain swap converts a Drosophila EGF receptor activator into an inhibitor

AUTOR(ES)

Schnepp, Bruce

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

In Drosophila the function of the epidermal growth factor (EGF) receptor is modulated zygotically by three EGF-like proteins: Spitz (Spi), which is a potent activator; Vein (Vn), which is a moderate activator; and Argos (Aos), which is an inhibitor. Chimeric molecules were constructed in which the EGF domain of Vn was swapped with the EGF domain from each factor. The modified Vn proteins behaved both in vitro and in vivo with properties characteristic of the factor from which the EGF domain was derived. These results demonstrate that the EGF domain is the key determinant that gives DER inhibitors and activators their distinct properties.

Documentos Relacionados

• The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1.
• Disease specificity of kinase domains: the src-encoded catalytic domain converts erbB into a sarcoma oncogene.
• The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function
• An α-Proteobacterium Converts Linear Alkylbenzenesulfonate Surfactants into Sulfophenylcarboxylates and Linear Alkyldiphenyletherdisulfonate Surfactants into Sulfodiphenylethercarboxylates
• A mutant Ebg enzyme that converts lactose into an inducer of the lac operon.